SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a reported deal with OpenAI to supply AI chips, potentially diversifying OpenAI's chip sources and impacting the AI hardware landscape. The community is buzzing about the long-term implications of this partnership, with some debating its impact on market share and AMD's valuation relative to competitors. Discussions also revolve around the financial structure of the deal and its potential benefits for both companies.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending due to reports of an SEC probe into its data collection practices, sparking debate about the company's growth and valuation. The community is actively discussing the potential impact of the investigation, with some viewing it as a buying opportunity and others anticipating further declines. Discussions also include whether this probe is part of a broader short seller campaign against the stock.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to a massive surge following FDA Breakthrough Therapy Designation, triggering a short squeeze amplified by its low float. The community is discussing potential continuation and comparing it to other high-flying biotech stocks, while also considering the possibility of a near-term offering. Some traders are highlighting the company's fundamentals and speculating on future price movement.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan is trending as community members discuss its potential as the 'Bitcoin of memecoins' and its strong community. Some users highlight the large number of zeros in its price, while others express excitement about potential gains and compare it to other popular meme coins like $PEPE and $HONK. The community also seems focused on holding for the long term, anticipating a significant increase in market cap.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid speculation of a potential tie-up with Tesla, fueled by a recent video featuring Archer's eVTOL alongside Tesla's Optimus robot. The community is actively discussing the possibility of a partnership announcement and its impact on the stock. Some believe this collaboration could revolutionize air mobility, while others urge caution due to regulatory challenges and the lack of official confirmation.

Society Pass, Inc. engages in the operation and acquisition of fintech and e-commerce platforms and mobile applications. It operates through the following segments: Online Food and Beverage (F&B) and Groceries Deliveries, Digital Marketing, Online Ticketing and Reservation, e-Commerce, Telecommunication Reseller, and Merchant Point of Sale (POS). The Online F&B and Groceries Deliveries segment includes the operation of Handycart, Mangan, and Pushkart brands. The Digital Marketing segment involves the engagement with creators and management of platforms. The Online Ticketing and Reservation segment focuses on the sale of domestic and overseas air ticket and global hotel reservations. The e-Commerce segment refers to the operation of an online lifestyle platform under the brand name Leflair. The Telecommunication Reseller segment consists of sales of local mobile phone plans and global internet data provider plans. The Merchant POS segment covers the sale of hardware and software. The company was founded by Luan Thuc Nguyen on June 22, 2018 and is headquartered in Carson City, NV.

Society Pass Inc

Society Pass is trending as traders discuss its potential for significant upward movement, drawing comparisons to other high-flying stocks. The community is focused on technical analysis, potential short squeezes, and a recently raised price target from Ascendiant Capital. Some are citing the company's underlying value and upcoming subsidiary IPOs as reasons for optimism.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending as community members discuss its potential as a leader in the burgeoning quantum computing sector, drawing comparisons to early NVIDIA and Tesla. Bullish investors highlight the company's existing revenue, enterprise clients, and government contracts as evidence of traction in a field often dismissed as hype. Concerns about valuation persist, with some arguing that traditional metrics fail to capture the disruptive potential of quantum computing and D-Wave's unique position with tested quantum applications.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CEL-SCI ($CVM) is trending amid news of a Breakthrough Medicine Designation application filed in Saudi Arabia for its cancer immunotherapy, Multikine, generating excitement for potential near-term revenue. The community is actively discussing the implications of this filing with potential partnerships and market entry, weighing the opportunity against the backdrop of the company's history and financial status. Some are skeptical, citing past failures and dilution concerns, while others remain bullish, anticipating a significant catalyst.

Doodles is a next-generation entertainment company focused on immersive storytelling through the creation and distribution of live and digital experiences, original content, and lifestyle products.  Doodles mission is to define the standard for immersive storytelling and color the world with joy.

Doodle Inu

Doodle Inu ($DOOD) is trending amid community excitement, with some suggesting it could be the next big meme coin in the dog-themed crypto space, drawing comparisons to $SHIB and $DOGE. The community is closely watching key price levels, anticipating a breakout and significant gains, while also highlighting a recent callout from a crypto influencer.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health ($OSCR) is trending amid speculation around the potential extension of ACA subsidies, with community members actively discussing its positive implications for the insurer. Talk centers on the potential for enrollment growth and reduced premium risks should the subsidies be maintained. Some traders anticipate a year-end rally, while others debate fair valuation and short squeeze potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership

TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which aims to evaluate the clinical utility of its...

Is the Options Market Predicting a Spike in Veracyte Stock?

Investors need to pay close attention to VCYT stock based on the movements in the options market lately.

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Veracyte (VCYT) is a Strong Growth Stock

VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up

Veracyte Q2 earnings and revenues beat estimates, fueled by Decipher and Afirma growth, sending shares up over 15%. 

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of +41.94% and +7.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Veracyte Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$36.04
Prev Close	$36.00
Open	$35.97
Dividend Yield	0.00%
50-Day Moving Average	$30.37
Beta	1.73
Avg. Volume	1M
PE Ratio	108.33

52-Week High	$47.32
52-Week Low	$22.61
Market Capitalization	$2.84B
EPS (Annual)	$0.3088
Price to Book	2.32
Revenue Per Employee	$540,975.73
Enterprise Value/EBITDA	N/A

VCYT
Veracyte Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VCYT News

VCYT Veracyte Inc